COL6A3 and breast cancer: Furthermore, ROC curves demonstrated that they had high diagnostic potential as BC biosignatures (Figure S3, Supplemental Digital Content, http://links.lww.com/MD/I152; CDH11 area under the ROC curve (AUC): 0.699, COL6A3 AUC: 0.697, EDNRA AUC: 0.833, SERPINF1 AUC: 0.804), suggesting the potential use of the genes as indicators in monitoring prognosis.